Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Dongxia Lin
Introduction
Dongxia Lin is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of diagnostic tools. His work focuses on enhancing the accuracy and reliability of medical testing.
Latest Patents
Dongxia Lin holds a patent for a reagent kit used for detecting lipoprotein-associated phospholipase A2. This innovative reagent kit includes one or more first anti-lipoprotein-associated phospholipase A2 antibodies that bind to the target enzyme. Additionally, it features second anti-lipoprotein-associated phospholipase A2 antibodies marked with a trace marker, which bind to a different site on the enzyme. The kit also contains a displacing agent to improve detection accuracy. This method allows for high sensitivity and repeatability in measuring the concentration of lipoprotein-associated phospholipase A2 in serum samples.
Career Highlights
Dongxia Lin is associated with Shenzhen New Industries Biomedical Engineering Co., Ltd. His work at this company has been instrumental in advancing biomedical technologies. He has collaborated with notable colleagues, including Wei Rao and Jinyun Yuan, to further enhance the capabilities of their research and development efforts.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Dongxia Lin's innovative work in the field of biomedical engineering exemplifies the impact of dedicated inventors on medical diagnostics. His contributions continue to pave the way for advancements in healthcare technology.